Newsletter | June 9, 2021

06.09.21 -- First Impressions Of Decentralized Trials

A Drug Developer’s First Experience With Decentralized Trials

When the FDA released new guidance for companies in May, it seemed every drug developer was scrambling to convert their clinical trials to a decentralized approach. Advicenne was no exception.

How CRO-Sponsor Partnerships Spurred Innovation In 2020

The clinical research industry in 2020 speedily adapted its practices to accomplish remarkable feats of rapid and high-quality vaccine and therapeutic development. This was atypical for the industry. To study this transition, the Avoca Industry Survey in 2020 focused on practices related to clinical research innovation, and in this article we draw from the data to explore the role played by CRO-sponsor relationships.

The 3-Step Approach To Unlock The Power Of Historical Trial Data

Many biopharmas still find it difficult to make sharing and using external trial data routine. How do we build on new momentum to continue and accelerate the use of historical trial data to transform R&D in the future?

From Bystander To Advocate For Diversity And Inclusion

In this executive virtual roundtable (EVR) segment, Edith Perez, M.D., chief medical officer at Bolt Biotherapeutics, an immuno-oncology company, discusses how she became involved in various diversity and inclusion initiatives, including The National Academies of Sciences, Engineering and Medicine, Stand Up To Cancer, Genentech, and The Mayo Clinic.

Special Edition #6: Tackling HR In Biopharma During A Pandemic

Three biopharmaceutical industry VPs of HR departments discuss the challenges of continued operations amidst COVID-19-initiated lockdowns, along with some of the best practices implemented.

Improving Diversity In Clinical Trials

A key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this e-book come from varying backgrounds, and, as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups.

June 2021 Digital Edition

Inside you will find more on:

  • Award Winners
  • Otsuka's Digital Technologies Focus
  • Decentralized Trials
  • Awards Philosophy

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.